| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |